High expression of nucleoside transporter protein hENT1 in Reed-Sternberg cells is associated with treatment failure in relapsed/ refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine and liposomal doxorubicin - A CALGB 59804 correlative study

Leukemia and Lymphoma

Volumn 49, Issue 6, 2008, Pages 1202-1205

  Lai, Raymond ^a   Bartlett, Nancy L ^a   Mackey, John R ^a   Jung, Sin Ho ^a   Johnson, Jeffrey L ^a   Cook, James R ^a   Jones, Dan ^a   Cass, Carol E ^a   Young, James D ^a   Said, Jonathan ^a   Cheson, Bruce ^a   Hsi, Eric D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; GEMCITABINE; NAVELBINE;

CANCER CELL CULTURE; CANCER GROWTH; CANCER RELAPSE; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFICACY; DRUG TREATMENT FAILURE; HODGKIN DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; LETTER; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REED STERNBERG CELL; RISK ASSESSMENT;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DEOXYCYTIDINE; DOXORUBICIN; EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1; FEMALE; HODGKIN DISEASE; HUMANS; LIPOSOMES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; REED-STERNBERG CELLS; SURVIVAL RATE; TREATMENT FAILURE; VINBLASTINE;

EID: 46749094286     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190802094237     Document Type: Letter

References (15)

1. Aurer, I., Radman, I., Nemet, D., Zupancic-Salek, S., Bogdanic, V. Mrsic, M. et al. (2005) Gemcitabine in the treatment of relapsed and refractory Hodgkin's disease. Onkologie, 28, pp. 567-571.
2. Baldwin, S. A., Beal, P. R., Yao, S. Y., King, A. E., Cass, C. E. and Young, J. D. (2004) The equilibrative nucleoside transporter family, SLC29. Pflugers Arch, 447, pp. 735-743.
3. Mackey, J. R., Baldwin, S. A., Young, J. D. and Cass, C. E. (1998) The role of nucleoside transport in anticancer drug resistance. Drug Resistance Updates, 1, pp. 310-324.
4. Mackey, J. R., Mani, R. S., Selner, M., Mowles, D., Young, J. D. Belt, J. A. et al. (1998) Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines. Cancer Res, 58, pp. 4349-4357.
5. Mackey, J. R., Yao, S YM Smith, K. M. et al. (1999) Gemcitabine transport in Xenopus oocytes expressing recombinant plasma membrane mammalian nucleoside transporters. J Natl Cancer Inst, 91, pp. 1876-1881.
6. Wiley, J. S., Taupin, J., Jamieson, G. P., Snook, M., Sawyer, W. H. and Finch, L. R. (1985) Cytosine arabinoside transport and metabolism in acute leukemias and T cell lymphoblastic lymphoma. J Clin Invest, 75, pp. 632-642.
7. Boumah, C. E., Hogue, D. L. and Cass, C. E. (1992) Expression of high levels of nitrobenzylthioinosine-sensitive nucleoside transport in cultured human choriocarcinoma (BeWo) cells. Biochem J, 288, pp. 987-996.
8. Reiman, T., Graham, K. A., Wong, J., Belch, A. R., Coupland, R. Young, J. et al. (2002) Mechanisms of resistance to nucleoside analogue chemotherapy in mantle cell lymphoma: A molecular case study. Leukemia, 16, pp. 1886-1887.
9. Spratlin, J., Sangha, R., Glubrecht, D., Dabbagh, L., Young, J. D. Dumontet, C. et al. (2004) The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma. Clin Cancer Res, 10, pp. 6956-6961.
10. Chow, L., Lai, R., Dabbagh, L., Belch, A., Young, J. D. Cass, C. E. et al. (2005) Analysis of human equilibrative nucleoside transporter 1 (hENT1) protein in non-Hodgkin's lymphoma by immunohistochemistry. Mod Pathol, 18, pp. 558-564.
11. Reiman, T., Clarke, M. L., Dabbagh, L., Vsianska, M., Coupland, R. W. Belch, A. R. et al. (2002) Differential expression of human equilibrative nucleoside transporter 1 (hENT1) protein in the Reed-Sternberg cells of Hodgkin's disease. Leuk Lymphoma, 43, pp. 1435-1440.
12. Wiley, J. S., Jones, S. P. and Sawyer, W. H. (1983) Cytosine arabinoside transport by human leukemic cells. Eur J Cancer Clin Oncol, 19, pp. 1067-1074.
13. Barlett, N. L., Niedzwiecki, D., Johnson, J. L., Friedberg, J. W., Johnson, K. B. van Besien, K. et al. (2007) Gemcitabine, Vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's Lymphoma: CALGB 59804. Ann Oncol, 18, pp. 1071-1079.
14. Cass, C. E., Dahlig, E., Lau, E. Y., Lynch, T. P. and Paterson, A RP (1979) Fluctuations in nucleoside uptake and binding if the inhibitor of nucleoside transport, nitrobenzylthioinosine, during the replication cycle of HeLa cells. Cancer Res, 39, pp. 1245-1252.
15. Smith, C. L., Pilarski, L. M., Egerton, M. L. and Wiley, J. S. (1989) Nucleoside transport and proliferative rate in human thymocytes and lymphocytes. Blood, 74, pp. 2038-2042.